You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Portable Transdermal Acoustic Patch for Delivery of Large Molecules to Improve HIV Patient Medication Regime Compliance by Elimination of Side Effects Including Injection Site Reactions

    SBC: ACTUATED MEDICAL, INC.            Topic: R

    DESCRIPTION provided by applicant This Phase IIB SBIR finalizes development conducts in depth preclinical testing and completes Verification and Validation of the Portable Transdermal Acoustic Patch TAP for Delivery of Large Molecules to Improve HIV Patient Medication Regime Compliance by Elimination of Side Effects Including Injection Site Reactions Nearly million people worldwide are ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. DEVELOPMENT OF TOPICAL ANTIVIRAL AGENTS FOR TREATING MOLLUSCUM CONTAGIOSUM

    SBC: FOX CHASE CHEMICAL DIVERSITY CENTER INC.            Topic: NIAID

    DESCRIPTIONprovided by applicantMolluscum contagiosumMCis a highly contagious skin disease caused by the poxvirusMCVMC appears as lesions on the body and face and can last months years before resolvingLesions occur most frequently in childrenand immune compromised individualsThe infection is confined to skin aloneit is not systemicTransmission spreads directly from person person contactautoinocula ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Prevention Economic Impact Model PEIM

    SBC: Mosaix Software, Inc.            Topic: R

    DESCRIPTION provided by applicant The proposed Fast Track SBIR grant application is for the creation of a Web based Interactive Prevention Economic Impact Model PEIM which enables substance abuse prevention organizations to select cost effective evidence based interventions for specific target populations and estimate the economic impact of prevention using service delivery data and ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Low Insertion Force Epidural Actuated Needle System for Enhanced Control and Tactile Feel During Epidural Insertion

    SBC: ACTUATED MEDICAL, INC.            Topic: 300

    DESCRIPTION provided by applicant In this NIH Phase IIB Competing Renewal SBIR project Actuated Medical Inc will finalize and clinically test the andquot Low Insertion Force Epidural LIFE Actuated Needle Insertion System for Enhanced Control and Tactile Feel andquot LIFE uses closed loop control of a vibrating needle to provide the clinician a more controlled entry through tough muscle a ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Integrated In Vitro and Alternative Ocular IIVAO Irritation Testing Strategy

    SBC: MB RESEARCH LABORATORIES, INC.            Topic: N

    DESCRIPTION provided by applicant Ocular irritation testing is extremely relevant to assuring adequate safety levels of public health as new formulations of chemicals and products are introduced In most cases these safety assessments are performed using the Draize Rabbit Eye test resulting in thousands of rabbits used in testing every year Alternatives have been discussed since the s with ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  6. A Phase a clinical trial of ALK in geographic atrophy

    SBC: ALKEUS PHARMACEUTICALS, INC.            Topic: NEI

    DESCRIPTION provided by applicant The long term goal of this work is to develop an oral drug for the prevention of age related macular degeneration AMD AMD is the leading cause of blindness in the United States with million Americans diagnosed or at risk of irreversibly losing vision and over million people who already have debilitating vision loss Currently there is no FDA approved ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Actuated Low Stress Endotracheal Tube Cleaner to Improve Neonate Lung Function

    SBC: ACTUATED MEDICAL, INC.            Topic: NICHD

    DESCRIPTION provided by applicant This Phase II SBIR finalizes development and clinically tests Neo ET Clear an Actuated Low Stress Endotracheal Tube ETT Cleaner to Improve Neonate Lung Function Neo ET Clear suctions mucus from mm diameter neonatal endotracheal tubes with significantly reduced deleterious impact on lung function and mechanics as compared to current methods includin ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Improving Clinical Encounter Communications to Enhance Minority Diabetes Care

    SBC: STARSHIP HEALTH TECHNOLOGIES LLC            Topic: NIMHD

    DESCRIPTION provided by applicant Disparities in healthcare delivery and outcomes have been linked in part to the difficulties physicians have in establishing effective communication with patients who differ from themselves in terms of race ethnicity and economic circumstances Type diabetes mellitus and pre diabetic nutrition based obesity are an important case in point Racial and socio ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Tolerability of SRX246 in Huntington's Disease Patients

    SBC: Azevan Pharmaceuticals Inc            Topic: 950

    DESCRIPTIONprovided by applicantHuntington s DiseaseHDis an inherited disease that results from expansion of a trinucleotideCAGcytosine adenine guaninerepeat that encodes a polyglutamine tract in the huntingtin proteinPsychiatric symptomsincluding irritability and aggressionare common in HD patientsThese are among the most distressing aspects of the diseaseThey have adverse effects on daily life a ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Epigenetic Probes for HMTs

    SBC: REACTION BIOLOGY CORPORATION            Topic: 100

    DESCRIPTION provided by applicant Epigenetic proteins such as histone methyltransferases represent important potential drug targets for indications like cancers neurodegenerative disorders and cardiovascular and metabolic diseases At Reaction Biology Corporation andquot RBCandquot we are working toward the complete coverage of all epigenetic targets including HMTs to identify and impr ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government